Protein 1 | Protein 2 | Combine Score |
---|---|---|
ALB | HPX | 0.976 |
HPX | LRP1 | 0.965 |
ALB | LRP1 | 0.945 |
HBB | HPX | 0.937 |
HBB | LRP1 | 0.901 |
# | 213 (ALB) | 3263 (HPX) | 3043 (HBB) | 4035 (LRP1) |
---|---|---|---|---|
213 (ALB) | 1.00 | 1.00 | 0.67 | 0.56 |
3263 (HPX) | 1.00 | 1.00 | 1.00 | 1.00 |
3043 (HBB) | 0.67 | 1.00 | 1.00 | 0.54 |
4035 (LRP1) | 0.56 | 1.00 | 0.54 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HPX | Rat | Lungs | - | 7600 m | 12 hours | downregulated | 1.4 | 2-DE | Northern indo-australian plate | Sprague-Dawley | 1 | Male SD rats weighing 220g | 26022216 |
HPX | Human | Plasma | - | 3500-4000m | Native | upregulated | 1.92 | 2-DE | Northern indo-australian plate | Ladakhi | 1 | Sea level healthy individuals | 23844025 |
HPX | Rat | Lungs | - | 7600 m | 6 hours | upregulated | 1.2 | 2-DE | Northern indo-australian plate | Sprague-Dawley | 1 | Male SD rats weighing 220g | 26022216 |
HPX | Rat | Lungs | - | 7600 m | 24 hours | upregulated | 1.9 | 2-DE | Northern indo-australian plate | Sprague-Dawley | 1 | Male SD rats weighing 220g | 26022216 |
HPX | Rat | Plasma | - | 7619 m | 24 hours | upregulated | 0.51 | 2-DE | Northern indo-australian plate | Male sprague-dawley | 1 | 8 weeks old male SD rats kept at standard conditions | 26882918 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|
ID | GO ID | GO Term | GO Type |
---|---|---|---|
3263 | GO:0015232 | L-serine transmembrane transporter activity | GOTERM_MF_DIRECT |
3263 | GO:0006879 | cellular iron ion homeostasis | GOTERM_BP_DIRECT |
3263 | GO:0060335 | positive regulation of interferon-gamma-mediated signaling pathway | GOTERM_BP_DIRECT |
3263 | GO:0005615 | extracellular space | GOTERM_CC_DIRECT |
3263 | GO:0042168 | heme metabolic process | GOTERM_BP_DIRECT |
3263 | GO:0046872 | metal ion binding | GOTERM_MF_DIRECT |
3263 | GO:0002639 | positive regulation of immunoglobulin production | GOTERM_BP_DIRECT |
3263 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | GOTERM_BP_DIRECT |
3263 | GO:0016032 | viral process | GOTERM_BP_DIRECT |
3263 | GO:0070062 | extracellular exosome | GOTERM_CC_DIRECT |
3263 | GO:0072562 | blood microparticle | GOTERM_CC_DIRECT |
3263 | GO:0006898 | receptor-mediated endocytosis | GOTERM_BP_DIRECT |
3263 | GO:0015886 | heme transport | GOTERM_BP_DIRECT |
3263 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein | GOTERM_BP_DIRECT |
3263 | GO:0005576 | extracellular region | GOTERM_CC_DIRECT |
3263 | GO:0005515 | protein binding | GOTERM_MF_DIRECT |
3263 | GO:0071682 | endocytic vesicle lumen | GOTERM_CC_DIRECT |
3263 | GO:0020027 | hemoglobin metabolic process | GOTERM_BP_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
HPX | 3263 | Acute Kidney Insufficiency | C1565662 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Autoimmune Diseases | C0004364 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | group |
HPX | 3263 | Hepatitis, Drug-Induced | C1262760 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Chemically-Induced Liver Toxicity | C4279912 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Compartment syndromes | C0009492 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | group |
HPX | 3263 | Kidney Failure, Acute | C0022660 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Drug-Induced Liver Disease | C0860207 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Acute kidney injury | C2609414 | Injury or Poisoning | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Chemical and Drug Induced Liver Injury | C4277682 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Drug-Induced Acute Liver Injury | C3658290 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Adverse reaction to drug | C0041755 | Pathologic Function | 0.3 | 0.648 | 0.621 | group |
HPX | 3263 | Hepatitis, Toxic | C0019193 | Injury or Poisoning | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Diabetes Mellitus, Non-Insulin-Dependent | C0011860 | Disease or Syndrome | 0.3 | 0.648 | 0.621 | disease |
HPX | 3263 | Drug toxicity | C0013221 | Injury or Poisoning | 0.3 | 0.648 | 0.621 | group |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|